Ledger.Open graph →
SEC Form D · filed September 13, 2017

TwinStrand Biosciences, Inc

Offering
$5.5M
Sold
$5.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Seattle, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Steve Dow · Somerville, MADirectorChad Waite, Jr · Bellevue, WAExec · DirectorLinden Rhoads · Bellevue, WADirectorChris Igielski · Kirkland, WAExec · DirectorLawrence Loeb · Bellevue, WADirector · PromoterJesse Salk · Bellevue, WAExec · Director · PromoterSteve Dow · San Francisco, CADirectorChad Waite, Jr · Bellevue, WAExec · DirectorLinden Rhoads · Bellevue, WADirectorChris Igielski · Kirkland, WAExec · DirectorLawrence Loeb · Bellevue, WADirector · PromoterJesse Salk · Bellevue, WAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗